Sergey Tselmin

966 total citations
27 papers, 276 citations indexed

About

Sergey Tselmin is a scholar working on Surgery, Neurology and Molecular Biology. According to data from OpenAlex, Sergey Tselmin has authored 27 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 7 papers in Neurology and 6 papers in Molecular Biology. Recurrent topics in Sergey Tselmin's work include Lipoproteins and Cardiovascular Health (13 papers), Long-Term Effects of COVID-19 (5 papers) and Platelet Disorders and Treatments (4 papers). Sergey Tselmin is often cited by papers focused on Lipoproteins and Cardiovascular Health (13 papers), Long-Term Effects of COVID-19 (5 papers) and Platelet Disorders and Treatments (4 papers). Sergey Tselmin collaborates with scholars based in Germany, United Kingdom and United States. Sergey Tselmin's co-authors include Stefan R. Bornstein, Ulrich Julius, Ulrike Schatz, Sabine Fischer, Richard Straube, Julio Licínio, Juergen Graessler, Roman N. Rodionov, Sandrine Thuret and Martin Achleitner and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecular Psychiatry and Atherosclerosis.

In The Last Decade

Sergey Tselmin

26 papers receiving 270 citations

Peers

Countries citing papers authored by Sergey Tselmin

Since Specialization

Citations

This map shows the geographic impact of Sergey Tselmin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergey Tselmin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergey Tselmin more than expected).

Fields of papers citing papers by Sergey Tselmin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergey Tselmin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergey Tselmin. The network helps show where Sergey Tselmin may publish in the future.

Co-authorship network of co-authors of Sergey Tselmin

This figure shows the co-authorship network connecting the top 25 collaborators of Sergey Tselmin. A scholar is included among the top collaborators of Sergey Tselmin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergey Tselmin. Sergey Tselmin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neutrophil Extracellular Traps (NETs) as a Potential Target for Anti-Aging: Role of Therapeutic Apheresis 2025 ·Hormone and Metabolic Research ·Natalia Jarzebska, Roman N. Rodionov, (unknown), Richard Straube, (unknown), Sergey Tselmin, (unknown), Ulrich Julius, Richard Siow, Jürgen Gräßler, Jens Passauer, Yannick P. Kok, (unknown), Norbert Weiss, Stefan R. Bornstein, (unknown)	2
2	Is it possible to regress atherosclerotic lesions with long-term treatment with lipoprotein apheresis? 2024 ·SHILAP Revista de lepidopterología ·Ulrich Julius, Sergey Tselmin, (unknown)	0
3	Results of Therapy at a Lipid Clinic in Patients with Elevated Lipoprotein(a) levels 2022 ·Ulrich Julius, (unknown), Sergey Tselmin, Ulrike Schatz, Norbert Weiss, Sabine Fischer	1
4	Post COVID and Apheresis – Where are we Standing? 2022 ·Hormone and Metabolic Research ·Charlotte Steenblock, (unknown), Sergey Tselmin, Natalia Jarzebska, (unknown), Nicole Toepfner, Timo Siepmann, Jens Passauer, Christian Hugo, (unknown), Ulrich Julius, Mahmoud Barbir, (unknown), Milo A. Puhan, Richard Straube, Bernd Hohenstein, Stefan R. Bornstein, Roman N. Rodionov	10
5	COVID-19 and Lipid Disorders 2022 ·Hormone and Metabolic Research ·Ulrich Julius, Ulrike Schatz, Sergey Tselmin, Henning Morawietz	9
6	Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis? 2021 ·Molecular Psychiatry ·Stefan R. Bornstein, (unknown), (unknown), Roman N. Rodionov, Raul R. Gainetdinov, Sergey Tselmin, Waldemar Kanczkowski, Gregor Müller, Martin Achleitner, Jun Wang, Julio Licínio, Michael Bauer, Allan H. Young, Sandrine Thuret, Nicole Bechmann, Richard Straube	56
7	Machine Learning Refutes Loss of Smell as a Risk Indicator of Diabetes Mellitus 2021 ·Journal of Clinical Medicine ·Jörn Lötsch, Antje Hähner, Peter E. H. Schwarz, Sergey Tselmin, Thomas Hummel	3
8	Short- and long-term effects of lipoprotein apheresis on plasma hormones in patients with therapy-resistant dyslipidemia 2019 ·Atherosclerosis Supplements ·(unknown), Ulrich Julius, Sergey Tselmin, Ulrike Schatz, Stefan R. Bornstein, J. Graessler	1
9	Actual situation of lipoprotein apheresis in patients with elevated lipoprotein(a) levels 2019 ·Atherosclerosis Supplements ·Ulrich Julius, Sergey Tselmin, Ulrike Schatz, Sabine Fischer, Andreas L. Birkenfeld, Stefan R. Bornstein	16
10	Experience with proprotein convertase subtilisin/kexine type 9 inhibitors (PCSK9i) in patients undergoing lipoprotein apheresis 2019 ·Atherosclerosis Supplements ·Sergey Tselmin, Ulrich Julius, (unknown), Stefan R. Bornstein, Ulrike Schatz	4
11	Extracorporeal apheresis therapy for Alzheimer disease—targeting lipids, stress, and inflammation 2019 ·Molecular Psychiatry ·Stefan R. Bornstein, (unknown), Peter Rosenthal, Sergey Tselmin, Ulrich Julius, Ulrike Schatz, Bernhard O. Boehm, Sandrine Thuret, Gerd Kempermann, Heinz Reichmann, George P. Chrousos, Julio Licínio, Ma‐Li Wong, Andrew V. Schally, Richard Straube	21
12	Cardiovascular risk factors in patients with premature cardiovascular events attending the University of Dresden Lipid Clinic 2019 ·Atherosclerosis Supplements ·Ulrike Schatz, Sabine Fischer, Gabriele Müller, Sergey Tselmin, Andreas L. Birkenfeld, Ulrich Julius, Winfried März, Stefan R. Bornstein	10
13	How effectively will PCSK9 inhibitors allow retrieval of freedom from apheresis in cardiovascular high risk patients? – Estimates form a large single center 2017 ·Atherosclerosis Supplements ·Bernd Hohenstein, Sergey Tselmin, Stefan R. Bornstein, Ulrich Julius	7
14	H.E.L.P apheresis exerts long term effects on the capacity of circulating proangiogenic cells 2017 ·Atherosclerosis Supplements ·Jan Sradnick, Sergey Tselmin, Andrea Wagner, Ulrich Julius, Vladimir Todorov, Christian Hugo, Bernd Hohenstein	1
15	Successful and well-tolerated bi-weekly immunoadsorption regimen in pemphigus vulgaris 2017 ·Atherosclerosis Supplements ·(unknown), Bernd Hohenstein, Sergey Tselmin, Ulrich Julius, Stefan R. Bornstein, Stefan Beissert, Claudia Günther	7
16	Low rate of infectious complications following immunoadsorption therapy without regular substitution of intravenous immunoglobulins 2017 ·Atherosclerosis Supplements ·Sergey Tselmin, Ulrich Julius, Stefan R. Bornstein, Bernd Hohenstein	3
17	LDL apheresis improves deranged cardiovagal modulation in hypercholesterolemic patients 2010 ·Atherosclerosis ·Manja Reimann, Ulrich Julius, (unknown), (unknown), Sergey Tselmin, Stefan R. Bornstein, Heinz Reichmann, Heinz Rüdiger, Tjalf Ziemssen	9
18	The Dresden Apheresis Center – experience with LDL apheresis and immunoadsorption 2009 ·Atherosclerosis Supplements ·Ulrich Julius, Sergey Tselmin, Sabine Fischer, Jens Passauer, Stefan R. Bornstein	22
19	Beyond lowering circulating LDL: Apheresis-induced changes of systemic oxidative stress markers by four different techniques 2009 ·Atherosclerosis Supplements ·Steffi Kopprasch, Juergen Graessler, Stefan R. Bornstein, Peter E. H. Schwarz, Sergey Tselmin, (unknown), (unknown), Ulrich Julius	19
20	Acute effects of lipid apheresis on human serum lipidome 2009 ·Atherosclerosis Supplements ·Sergey Tselmin, Gerd Schmitz, Ulrich Julius, Stefan R. Bornstein, Andreas Barthel, Juergen Graessler	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact